Featured Story | By Annalee Armstrong Last night, the Centers for Medicaid & Medicare Serviced finalized its ruling restricting coverage of Biogen’s Aduhelm to only those participating in an approved clinical trial. But the ruling left the door open for therapies to come from Eli Lilly and Genentech, with a few caveats. read more |
| |
|---|
|
Top Stories By Max Bayer Kaleido Therapeutics failed to find a buyer, so it's closing up shop. That means its remaining staff are out of a job and the company is delisting, a disappointing end to hopes that it could tap the microbiome for new therapies. read more By Nick Paul Taylor Genfit’s phase 3 liver disease clinical trial has recovered quickly from the short, sharp shock of the winter omicron wave, enabling it to reaffirm its targeted readout despite the disruption caused by the variant. read more Sponsored by: Evidation Health Evidation and BARDA researchers were able to directly recruit subjects for a COVID-19 study via mobile app, & create an AI risk model, while recruiting a representative cohort. read more By Annalee Armstrong In just 72 words, BioCryst announced it would pause enrollment for three phase 2 trials of its rare disease candidate BCX9930, sending shares tumbling 30%. read more By Nick Paul Taylor Delays to GenSight Biologics’ eye disease gene therapy are leading toward a cash crunch. With the cash runway due to end early next year and Lumevoq still being reviewed in Europe, GenSight is looking into “several financing options” to enable it to launch the gene therapy in 2023. read more By Gabrielle Masson Biophytis has had to limit data collection, delay studies and end patient enrollment early for certain studies, a disruption brought on by the pandemic that has impacted multiple pillars of the pipeline. read more By Andrea Park The C2inform test’s findings can be used not only to detect lasting signs of cancer but also to keep track of its progression and monitor how well various treatments are working. read more By Angus Liu The Centers for Medicare & Medicaid Services has maintained its restrictive stance on Aduhelm. Now, it’s time for the drug’s developer, Biogen, to do some serious rethinking—including, as one analyst suggests, ceasing commercialization. read more By Paige Minemyer The pandemic has put social determinants of health and inequities into the spotlight. But a new study from Humana aims to highlight how common these challenges were among seniors before COVID-19 hit. read more By Fraiser Kansteiner All told, Kewalramani collected around $15.19 million last year, a 50% increase over the $9.11 million she made in 2020. Back in 2020, Kewalramani’s total compensation was about half the final-year pay for Vertex’s former CEO—and current executive chairman—Jeffrey Leiden, who scored nearly $18.8 million in his last year at the helm. read more By Max Bayer Fierce Biotech is launching the Fierce Biotech Layoff Tracker amid mounting job cuts in the industry since the start of the year. Novartis says bye to CMO John Tsai after four years amid a corporate restructuring. Lauded stem cell researcher Doug Melton joins Vertex to further explore stem cell biology in pursuit of new therapies. read more By Angus Liu Legend Biotech's co-founder has left the company without a new job. Takeda has signed on Evozyne to do protein work for gene therapies. Pfizer has launched a voluntary retirement scheme in India amid a digital push. And more. read more Resources Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Presented By: Springer Nature The journey of drug development in 2021 delivered to your inbox: top 10 AdisInsight drug profiles viewed, new drug profiles released, overview of drug launches, key deals, research trends in 2021 and much more (free of charge). Sponsored by: Blue Matter, strategic consultants in the life sciences What’s in store for the oncology market in 2022 and beyond? This paper looks at 5 trends driving the market. Sponsored by: Thermo Fisher Scientific Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific. Sponsored by: Medidata, a Dassault Systèmes company The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates. Sponsored by: Thermo Fisher Scientific Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow. Sponsored by: Oracle Health Sciences Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Accelerating Immuno-Oncology and Oncology Drug Development Using Humanized Mice Live & Recorded on: Thursday, April 21, 2022 | 12pm ET / 9am PT Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
